| Name | SP-2-225 |
|---|
| Description | SP-2-225 is a selective HDAC6 inhibitor. SP-2-225 enhance the production of cancer-associated antigens and macrophage antigen cross-presentation to T cells. SP-2-225 reduces the tumor volume in a syngeneic SM1 melanoma model[1]. |
|---|---|
| Related Catalog | |
| Target |
HDAC6[1] |
| References |
| Molecular Formula | C28H34N2O3 |
|---|---|
| Molecular Weight | 446.58 |